Stryker Corporation (SYK) receives a low valuation ranking of 33 from Investors Observer data analysis. The proprietary ranking system focuses on the underlying health of a business by analyzing its stock price, earnings, and rate of growth. SYK is worth better than 33% of the stocks based on these valuation analyzes. Investors primarily focused on buy and hold strategies will find the valuation ranking relevant to their goals when making investment decisions.
SYK achieves an evaluation ranking of 33 today. Find out what this means to you and get the rest of the leaderboard on SYK!
SYK’s 12-month price-to-earnings (PE) ratio of 49.8 puts it above the all-time average of around 15. SYK is poor value at its current trading price as investors pay more than it. that it is worth in relation to the company’s profits. . SYK’s last 12-month earnings per share (EPS) of 5.46 does not justify what it is currently trading in the market. Tracking PE ratios, however, do not take into account a company’s projected growth rate, resulting in some companies having high PE ratios due to high growth potentially attractive to investors even though current earnings are weak. SYK has a 12-month forward PEG to Growth Ratio of 2.99. The markets are overvaluing SYK relative to its projected growth, as its PEG ratio is currently above fair market value of 1. The PEG of 5.46000003 comes from the fact that its forward price / earnings ratio is divided by its growth rate. PEG ratios are one of the most widely used valuation metrics due to the incorporation of more fundamental business metrics and the focus on the future of the business rather than its past.
SYK’s valuation measures are weak at its current price due to an overvalued PEG ratio despite strong growth. SYK’s PE and PEG are below the market average, resulting in a lower than average review score. Click here for the full Stryker Corporation (SYK) Stock Report.
It is with great sadness that Indium Corporation announces the passing of President William (Bill) N. Macartney III on September 14, 2021.
Macartney leaves behind a business he has served faithfully for over 50 years. Macartney joined in 1967 and was named president in 1970. He was named president in 2017.
Over these many decades, Indium Corporation has experienced steady and steady growth and significant market expansion. Under Macartney, Indium Corporation grew from around 20 employees to nearly 1,200 today and from a factory in Utica, NY, USA to 14 modern and ever-expanding facilities around the world.
“Characteristics of Bill’s leadership were his dedication to the people who worked for him, his concern for the community, and his commitment to customers who relied on Indium Corporation to deliver exceptional products that truly made an impact on the world. Said Greg Evans, CEO.
“Bill believed that materials science changed the world and made it a fundamental part of the culture of Indium Corporation,” said Ross Berntson, president and chief operating officer. “It provided the platform for our team to continuously search for the next technological advancement.”
The appointment of a new President will be made at the discretion of the Board of Directors. Evans remains CEO and Ross Berntson remains president and chief operating officer.
MIAMI, September 22, 2021– (COMMERCIAL THREAD) – JAWS Spitfire Acquisition Corporation (“JAWS Spitfire“) (NYSE: SPFR), announced today that due to public health and safety concerns related to the current coronavirus (COVID-19) pandemic, it is highly encouraging for shareholders to attend the meeting General Meeting of its shareholders, to be held on September 28, 2021 at 9:00 a.m. New York time (the “General assembly“), by teleconference rather than in person. The purpose of the General Assembly is to vote on certain proposals relating to the previously announced merger between JAWS Spitfire and Velo3D, Inc. (“BIKE3d“or the”Society“), the related Business Combination Agreement, dated March 22, 2021 (as amended or supplemented from time to time, on”Business combination agreement“), and the other transactions contemplated therein (collectively, the”Commercial combination“).
BIKE3d allows companies to imagine more and additively manufacture almost anything. Bringing together an integrated end-to-end solution of software, hardware and process control innovations, VELO3D ‘Metal 3D printing technology provides unmatched quality control for mass production and improved part performance. With BIKE3d Flow ™ print preparation software, Sapphire® laser powder bed AM system and Assure ™ quality assurance software, manufacturers can accelerate product innovation, become more agile and responsive to market needs and reduce costs. The first in the industry to introduce SupportFree metal 3D printing, which enables the fabrication of previously impossible geometries, the company is based in Silicon Valley and is privately funded. BIKE3d was named to Fast Company’s prestigious annual list of the world’s most innovative companies for 2021. For more information, please visit https://www.velo3d.com/.
About JAWS Spitfire Acquisition Corporation
JAWS Spitfire Acquisition Corporation, led by Chairman Barry S. Sternlicht and Chief Executive Officer Matthew Walters, is a blank check company incorporated as a Cayman Islands exempt corporation for the purpose of effecting a merger, exchange of ‘shares, an acquisition of assets, a purchase of shares, a reorganization or similar business combination with one or more companies or entities.
In connection with the business combination, JAWS Spitfire has filed, and the SEC has declared effective, a registration statement on Form S-4 containing a proxy circular / final prospectus. JAWS Spitfire has sent the Management Proxy Circular / Final Prospectus and other relevant documents relating to the business combination to its shareholders. This Current Report does not contain all the information that should be taken into account regarding the Business Combination and is not intended to form the basis of an investment decision or any other decision regarding the Business Combination. Investors and holders of securities of JAWS Spitfire are encouraged to read the proxy circular / final prospectus in connection with the solicitation of proxies of JAWS Spitfire for the General Meeting to be held to approve the business combination. other documents filed in connection with the business combination, as these documents will contain important information about the business combination and the parties to the business combination. The Proxy Circular / Final Prospectus was sent to the shareholders of JAWS Spitfire on the registration date of August 27, 2021; shareholders who hold their shares in registered form have the right to vote for their shares held on the day of the General Meeting. Shareholders may also obtain free copies of the Proxy Circular / Final Prospectus and other documents filed with the SEC on the SEC website at www.sec.gov or by directing a request to: JAWS Spitfire Acquisition Corporation, 1601 Washington Avenue, Suite 800, Miami Beach, FL 33139.
Participants in the call for tenders
JAWS Spitfire, the Company and their respective directors, officers, other officers and employees, under the rules of the SEC, may be considered participants in the solicitation of proxies from the shareholders of JAWS Spitfire in connection with the Combination. companies. Investors and security holders can obtain more detailed information regarding the names and interests in the business combination of the directors and officers of JAWS Spitfire in the documents filed by JAWS Spitfire with the SEC, including the proxy circular. / the final prospectus of JAWS Spitfire for the business combination.
The Company and its directors and officers may also be considered participants in the solicitation of proxies from the shareholders of JAWS Spitfire in connection with the Business Combination. A list of the names of such directors and officers and information regarding their interests in the business combination is included in the proxy circular / final prospectus for the business combination.
This current report is not a statement of proxy or a solicitation of proxy, consent or authorization with respect to any security or with respect to the potential transaction and does not constitute an offer to sell or a solicitation of an offer to purchase securities of JAWS Spitfire or the Company, and there shall be no sale of such securities in any state or jurisdiction in violation of applicable law. No offer of securities will be made except by means of a prospectus meeting the requirements of the securities law.
Certain statements made in this report are not historical facts but are forward-looking statements for the purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Forward-looking statements are usually accompanied by words such as “to believe, “”may, “”will, “”estimate, “”Carry on, “”to anticipate, “”intend, “”wait, “”should, “”would have, “”plan, “”to predict, “”potential, “”appear, “”to look for, “”future, “”outlook“and similar expressions which predict or indicate future events or trends or which are not statements about historical matters. These forward-looking statements include, without limitation, statements concerning future events, business combinations between JAWS Spitfire and the company, the estimated or anticipated future results and benefits of the combined company as a result of the business combination, including the likelihood and ability of the parties to successfully complete the business combination, future opportunities for the combined company and other statements that are not historical facts.
These statements are based on the current expectations of JAWS Spitfire management and are not actual performance predictions. These forward-looking statements are provided for informational purposes only and are not intended to serve as a guarantee, assurance, prediction or definitive statement of fact or probability to an investor and should not be relied upon by an investor. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many real events and circumstances are beyond the control of JAWS Spitfire and the Company. These statements are subject to a number of risks and uncertainties relating to the business of JAWS Spitfire and the business combination, and actual results could differ materially. These risks and uncertainties include, without limitation, general economic, political and business conditions; the inability of the parties to complete the Business Combination or the occurrence of any event, change or other circumstances which could result in the termination of the Business Combination Agreement; the outcome of any legal proceedings that may be initiated against the parties following the announcement of the Business Combination; receiving an unsolicited offer from another party for an alternative business transaction that could interfere with the business combination; the risk that the approval of the shareholders of JAWS Spitfire or of the Company for the potential transaction will not be obtained; failure to realize the expected benefits of the business combination, including due to a delay in completing the potential transaction or difficulty integrating the business of JAWS Spitfire and the Company; the risk that the Business Combination will disrupt current plans and operations following the announcement and completion of the Business Combination; the combined ability of the business to grow and manage its growth profitably and to retain key employees; the amount of redemption requests made by shareholders of JAWS Spitfire; the inability to obtain or maintain the listing of the company’s shares post-acquisition on NYSE following the Business Combination; costs related to the Business Combination; and the factors discussed in the JAWS Spitfire proxy circular / final prospectus relating to the business combination, including those under “Risk Factors” and other documents filed with the SEC. There may be additional risks that JAWS Spitfire is not currently aware of or that JAWS Spitfire currently considers to be immaterial, which could also cause actual results to differ from those contained in forward-looking statements. In addition, forward-looking statements provide JAWS Spitfire’s expectations, plans or forecasts regarding future events and opinions as of the date of such communication. JAWS Spitfire anticipates that subsequent events and developments will cause JAWS Spitfire ratings to change. However, although JAWS Spitfire may choose to update these forward-looking statements at some time in the future, JAWS Spitfire expressly disclaims any obligation to do so. These forward-looking statements should not be taken as representing evaluations of JAWS Spitfire as of a date after the date of this communication.
Nothing in this current report should be construed as a representation by any person that the forward-looking statements set forth herein, including the expected results of such forward-looking statements, will be achieved. Therefore, one should not place undue reliance on forward-looking statements.
WILSON, Wyoming, September 22, 2021 (GLOBE NEWSWIRE) – SynAgile Corporation ( www.SynAgile.com ), a private pharmaceutical company that develops and markets drug delivery systems using its proprietary OraFuse® technology platform, today announced the closing of a convertible debt investment of more than $ 9 million . Proceeds from the sale will be used to complete the Phase 2 clinical trial of the DopaFuse® Delivery System and initiate larger scale production for its Phase III trial. The Phase II trial is currently underway in Luxembourg, Italy and Spain. The DopaFuse delivery system is the first non-invasive and continuous delivery system for levodopa-carbidopa. DopaFuse has the potential to treat motor fluctuations and dyskinesias associated with Parkinson’s disease.
Along with the funding, Mr. Michael McNamara joined the SynAgile Board of Directors. Mr. McNamara spent 12 years as CEO of Flex, one of the world’s largest multinational technology manufacturing companies, where he grew the company to $ 25 billion in revenue and over 200,000 employees operating in more than 30 countries. Mr. McNamara sits on the boards of Carrier, Workday and PCH International, and has served on the boards of many other companies, including Slack Technologies, Delphi, SunEdison and Therasense. He is also a venture capital partner at Eclipse Ventures.
SynAgile also announces the appointment of Dr. C. Warren Olanow as Medical Director of SynAgile. Dr Olanow has been an advisor to SynAgile since 2011. He is the past chair of the Department of Neurology at the Mount Sinai School of Medicine in New York. Dr. Olanow is the co-founder and CEO of Clintrex, a clinical research company. Dr. Olanow’s research has focused on the cause and treatment of PD and other neurodegenerative diseases. He has led several pivotal clinical trials leading to the approval of numerous drugs and is the recipient of the 2013 American Academy of Neurology Movement Disorders Research Award and Lifetime Achievement Award from the International Parkinson and Movement Disorder Society.
SynAgile is a pharmaceutical company focused on the development and commercialization of therapeutic products using its patented continuous, non-invasive oral dosing technology, OraFuse®, initially focusing on the treatment of debilitating motor complications in patients with Parkinson’s disease using its DopaFuse® levodopa-carbidopa delivery system.
Starbucks Corporation (SBUX) shares have risen 34.22% in the past 12 months, and the average rating for Wall Street analysts is Buy. Investors Observer proprietary ranking system, gives the SBUX stock a possible score of 67 out of 100. This ranking is primarily influenced by a short-term technical score of 86. The SBUX ranking also includes a long-term technical score of 71. The fundamental score for SBUX is 45. In addition to the average Wall Street analyst score , SBUX stock has an average target price of $ 128.67. This means that analysts expect the stock to rise 14.27% over the next 12 months.
SBUX has an overall score of 67. Find out what that means to you and get the rest of the leaderboard on SBUX!
What’s going on with SBUX Stock today
Shares of Starbucks Corporation (SBUX) rose 0.7% while the S&P 500 rose 0.1% at 2:05 p.m. on Tuesday, September 21. SBUX was up $ 0.78 from the previous closing price of $ 111.82 on a volume of 3,203,113 shares. Over the past year, the S&P 500 has gained 32.95% while the SBUX is up 34.22%. SBUX has earned $ 2.39 per share over the past 12 months, giving it a price-to-earnings ratio of 47.15. Click here for the full Starbucks Corporation Stock Report.
PUBLIC OPENING POSITION DISCLOSURE / TRANSACTION DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3of the OPA Code (the “Code”)
(a)Full name of whistleblower:
Man Group API
(b)Owner or controller of the disclosed interests and short positions, if different from 1 (a): TInsufficient designation of agent or vehicle companies. For a trust, the trustee (s), component and beneficiaries must be named.
(vs)Name of the offeror / officer with regard to the titles concerned this form reports: Use a separate form for each offeror / beneficiary
(D)If an exempt fund manager is related to an offeror / offeror, indicate this and specify identity of offering / offering:
(e)Date of the position held / of the transaction undertaken: For an open position disclosure, state la latest practicable date before disclosure
20/ 09/ 2021
(F)In addition to the company in 1 (c) above, is the discloser make disclosures with regard to everything other party to the offer? If it is a cash offer or cash offer possible, indicate “N/A“
YES / NO / N / A If YES, specify which one:recipient:Games Plc group
2.POSITIONS OF THE DISCLOSING PERSON
If there are positions or rights to be subscribed to be disclosed in more than one category of relevant securities of the offeror or the offender named in point 1 (c), copy table 2 (a) or (b) (depending on the case) for each additional category of relevant titles. Security.
(a)Interest and short positions in securities of the offeror or pollicity to which the disclosure relates as a result of the transaction(if only)
Relevant safety class:
Common $ 0.01
(1)Relevant securities held and / or controlled:
– 2 204
(3)Equity-settled derivatives (including options) and purchase / sale agreements:
All interests and all short positions must be disclosed.
Details of any opening settled in actions derivative posts (including traded options), or the relevant securities purchase or sale agreements, should be given on an additional form8 (Open positions).
(b)Subscription rights for new titles (including directors and others employee option)
Relevant safety class for which a subscription right exists:
Details, including the nature of the rights concerned and the relevant percentages:
3.RELATIONSHIPS (IF APPLICABLE) BY THE PERSON MAKING THE DISCLOSURE
When there have been transactions on more than one category of relevant securities of the offeror or offender named in point 1 (c), copy table 3 (a), (b), (c) or (d ) (as the case may be) for each class of securities concerned processed.
The currency of all prices and other monetary amounts must be indicated.
(a)Purchases and sales
Relevant safety class
Number of titles
Price per unit
Common $ 0.01
Common $ 0.01
(b)Cash-settled derivative transactions
Relevant safety class
Product Description for example CFD
Nature of transaction for example opening/ close a long/short position, increasing / decreasinga long/short position
(D)Other transactions (including to subscribe to new titles)
Relevant safety class
Nature of transaction for example subscription, conversion
Unit price (if applicable)
(a)Compensation and other trade agreements
Ddetails of everything indemnity or option arrangement, Where any agreement or agreement, formal or informal, relating to relevant securities which may be an inducement to trade or refrain from trading entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not to be understood. Yes there are no such agreements, arrangements or understandings, State “nothing“
(b)The agreements, provisions or agreements relating to options or derivatives
Ddetails of any agreement, arrangement or arrangementformal or informal, between the person make the disclosure and any other person related to:
(I)the voting rights of any security concerned under any option; Where (ii)voting rights or the future acquisition or disposal of any relevant security to which any derivative is referenced: If there are no such agreements, arrangements or understandings, State “nothing“
Is a Supplementary form 8 (Open positions) attached?
21/ 09/ 2021
Name of the contact:
Public disclosures under Rule 8 of the Code must be made to a regulatory information service.
The Panel’s Market Surveillance Unit is available for consultation regarding the Code’s disclosure requirements on +44 (0) 20 7638 0129.
The Code can be viewed on the Group’s website at www.thetakeoverpanel.org.uk.